A surge of enthusiasm grips Vapi’s business circles over the groundbreaking India-EU Free Trade Agreement, positioning it as a counterbalance to US tariff adversities. This Gujarat industrial epicenter, boasting 10,000 diverse SMEs, is poised for exponential growth.
Dominating sectors like engineering, paper, textiles, pharma, and chemicals have faced headwinds from Trump tariffs, prompting a hunt for fresh markets. The EU pact delivers exactly that, streamlining trade and fortifying export capabilities.
Dr. Kamal Wasi from Mangalam Drugs highlighted the pharma boom: ‘No more tariff walls in Europe—India’s generic prowess will dominate, rescuing our sector from US blows.’
Influential figure Shard Thakar called it a landmark achievement under PM Modi. ‘This superior agreement heals tariff-inflicted wounds, simplifies EU business, and secures industrial futures.’
Satyish Patel, Vapi Industries Association President, termed it the ‘mother of all deals,’ vital for pharma, pesticides, and beyond. ‘It unlocks Europe’s potential, offsets US losses, and advances Viksit Bharat goals.’
The deal’s dual import-export advantages promise cost efficiencies, job growth, and tech infusions. Vapi’s entrepreneurs foresee a vibrant era, cementing its role in India’s global trade narrative.